Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 33, Issue 3, Pages 327-337
Publisher
Wiley
Online
2012-11-24
DOI
10.1111/liv.12083
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy
- (2012) Jie-Wen PENG et al. Asia-Pacific Journal of Clinical Oncology
- The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma
- (2012) Xu-Dong Qu et al. BMC CANCER
- Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study
- (2012) Wolfgang Sieghart et al. EUROPEAN RADIOLOGY
- Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
- (2012) Joong-Won Park et al. JOURNAL OF HEPATOLOGY
- Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
- (2012) Marta Burrel et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial
- (2012) D. Sansonno et al. ONCOLOGIST
- The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma
- (2011) R. Cabrera et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
- (2011) Masatoshi Kudo et al. EUROPEAN JOURNAL OF CANCER
- Selective and sequential transarterial chemoembolization: Survival in patients with hepatocellular carcinoma
- (2011) Gerald Antoch et al. EUROPEAN JOURNAL OF RADIOLOGY
- Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation
- (2011) Bruno Sangro et al. HEPATOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
- (2011) Timothy M. Pawlik et al. JOURNAL OF CLINICAL ONCOLOGY
- Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma
- (2011) Hwi Young Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- 79 SORAFENIB PLUS TACE FOR THE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA – FINAL RESULTS OF THE SOCRATES TRIAL
- (2011) A. Erhardt et al. JOURNAL OF HEPATOLOGY
- Radioembolization for hepatocellular carcinoma
- (2011) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma
- (2011) Chia-I. Lin et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Selective internal radiation therapy (SIRT) in primary or secondary liver cancer
- (2011) L. Prompers et al. METHODS
- Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma
- (2011) Markus Peck-Radosavljevic et al. WIENER KLINISCHE WOCHENSCHRIFT
- Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma
- (2010) Brian I. Carr et al. CANCER
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
- (2010) J.-L. Raoul et al. CANCER TREATMENT REVIEWS
- Transcatheter Arterial Chemoembolization with Epirubicin-Loaded Superabsorbent Polymer Microspheres for 135 Hepatocellular Carcinoma Patients: Single-Center Experience
- (2010) Akihiko Seki et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- The intermediate hepatocellular carcinoma stage: Should treatment be expanded?
- (2010) Fabio Piscaglia et al. DIGESTIVE AND LIVER DISEASE
- Radioembolization with Use of Yttrium-90 Resin Microspheres in Patients with Hepatocellular Carcinoma and Portal Vein Thrombosis
- (2010) Mercedes Iñarrairaegui et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Transcatheter arterial chemoembolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma
- (2010) Kazuhiro Kasai WORLD JOURNAL OF GASTROENTEROLOGY
- Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China
- (2010) Ming Shi WORLD JOURNAL OF GASTROENTEROLOGY
- Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma
- (2009) Katerina Malagari et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Transcatheter Arterial Chemoembolization (TACE) with Lipiodol to Treat Hepatocellular Carcinoma: Survey Results from the TACE Study Group of Japan
- (2008) Mituo Satake et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search